Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1998-1-26
pubmed:abstractText
Catecholamines play a central role in the regulation of energy expenditure, in part by stimulating lipid mobilization through lipolysis in fat cells. The beta-2 adrenoceptor (BAR-2) is a major lipolytic receptor in human fat cells. To determine whether known polymorphisms in codons 16, 27, and 164 of this receptor play a role in obesity and subcutaneous adipocyte BAR-2 lipolytic function, we investigated a group of 140 women with a large variation in body fat mass. Only the polymorphisms in codons 16 and 27 were common in the study population. The Gln27Glu polymorphism was markedly associated with obesity with a relative risk for obesity of approximately 7 and an odds ratio of approximately 10. Homozygotes for Glu27 had an average fat mass excess of 20 kg and approximately 50% larger fat cells than controls. However, no significant association with changes in BAR-2 function was observed. The Arg16Gly polymorphism was associated with altered BAR-2 function with Gly16 carriers showing a fivefold increased agonist sensitivity and without any change in BAR-2 expression. However, it was not significantly linked with obesity. These findings suggest that genetic variability in the human BAR-2 gene could be of major importance for obesity, energy expenditure, and lipolytic BAR-2 function in adipose tissue, at least in women.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-2742143, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-2832197, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-3025863, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-6093156, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-7609750, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-7609751, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-7609752, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-7706471, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-7738189, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-7901205, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-7915137, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8200997, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8371057, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8383511, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8535093, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8561156, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8590354, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8641219, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8710237, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8721782, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8787941, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8817112, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8851509, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8898192, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8903328, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-8971085, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-9023606, http://linkedlifedata.com/resource/pubmed/commentcorrection/9399946-9054940
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3005-13
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.
pubmed:affiliation
Department of Medicine, and Research Center, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't